Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Acquired by Federated Hermes Inc.

Federated Hermes Inc. lifted its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 3.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 32,720 shares of the company’s stock after purchasing an additional 953 shares during the period. Federated Hermes Inc.’s holdings in Establishment Labs were worth $1,507,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. R Squared Ltd purchased a new stake in shares of Establishment Labs during the fourth quarter worth $36,000. Swiss National Bank grew its stake in Establishment Labs by 2.7% during the 4th quarter. Swiss National Bank now owns 38,500 shares of the company’s stock worth $1,774,000 after purchasing an additional 1,000 shares in the last quarter. Handelsbanken Fonder AB increased its holdings in Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after purchasing an additional 2,000 shares during the period. HighTower Advisors LLC raised its position in Establishment Labs by 32.5% in the 3rd quarter. HighTower Advisors LLC now owns 10,311 shares of the company’s stock valued at $446,000 after purchasing an additional 2,529 shares in the last quarter. Finally, SkyView Investment Advisors LLC boosted its stake in shares of Establishment Labs by 30.5% in the 3rd quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company’s stock valued at $519,000 after buying an additional 2,805 shares during the period. 72.91% of the stock is owned by hedge funds and other institutional investors.

Establishment Labs Price Performance

Shares of NASDAQ:ESTA opened at $31.32 on Tuesday. The company’s fifty day moving average price is $36.45 and its 200 day moving average price is $39.99. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 12 month low of $26.56 and a 12 month high of $60.12. The firm has a market capitalization of $903.46 million, a P/E ratio of -12.14 and a beta of 0.77.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The firm had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. As a group, sell-side analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ESTA has been the topic of several analyst reports. Needham & Company LLC assumed coverage on shares of Establishment Labs in a report on Monday. They issued a “hold” rating on the stock. Stephens restated an “overweight” rating and issued a $52.00 price objective on shares of Establishment Labs in a report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.